Navigation Links
Neptune Technologies patent granted for novel phospholipids in multiple diseases and pharmaceutical applications
Date:3/27/2008

- Composition of Matter Patent Granted and Enforceable in 24 European

Countries - Competitors Precluded from Immediate Commercialization of Competitive

Products

LAVAL, QC, March 27 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) announces that the European Patent Office (EPO) granted on May 31st 2007 Neptune's composition of matter patent entitled "Natural Marine Source Phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications" (EP01417211B1) and that this patent has now been issued and validated in twenty-four European countries.

This patent is directed to the use of Neptune marine phospholipid and flavonoid compositions as a medicament for the prevention and treatment of multiple chronic health conditions, including coronary artery disease caused by hypercholesterolemia, peripheral vascular disease, neurodegenerative and other cognitive disorders.

"This composition of matter patent is a critical achievement that constitutes a key component for our commercial pharmaceutical development program," said Dr. Tina Sampalis, Chief Scientific Officer of Neptune. "Neptune's mission has always been the development of innovative pharmaceutical ingredients, and this patent is viewed as a vital element towards Neptune's pharmaceutical initiatives. Its enforcement is a major accomplishment and a step forward," she added.

As part of the EPO procedure, within a nine-month period following the date of granting of the European patent, a notice of opposition can be filed in writing with the EPO. In the case of Neptune, oppositions were filed by Norway-based Aker BioMarine and Israel-based Enzymotec. The opposition proceedings are a multi-year (5-7 year) procedure with the potential outcome of maintaining the patent, amending it or, in certain cases, revoking it. According to EPO regulations,
'/>"/>

SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Neptune Technologies expands into medicinal markets in Asia Pacific
2. Neptune Technologies receives GRAS notification in the United States
3. Neptune Technologies & Bioressources Inc. obtains Complementary Medicine approval in Australia for NKO(R)
4. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
5. Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board
6. Neptune Technologies & Bioressources Inc. Reports First Quarter Results and Business Update
7. Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results
8. Senesco Technologies Regains Compliance With Amexs Continued Listing Requirements
9. Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
10. Millennium Biotechnologies, Inc. Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals
11. Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...e EuroPCR08 will highlight choice of different mod...imaging platform., SAN DIEGO, and BRUSSELS, Belgi...ration (Nasdaq: VOLC ), a leading manufacturer an...nctional measurement (FM) and Optical,Coherence To...agnosis and,treatment of coronary and peripheral v...
(Date:5/12/2008)... PARSIPPANY, N.J., May 12 /...based pharmaceutical company, and,Daiichi Sankyo, ...ir,co-promotion agreement for AZOR(TM)* (amlodipin...d-dose combination of two antihypertensives, the,c... angiotensin receptor,blocker olmesartan medoxomil...
(Date:5/12/2008)...- Conference Call at 10:30 a.m. ET, May 13 -, EME...Neurobiological,Technologies, Inc. (NTI(R)) (Nasda...ts fiscal third quarter and the nine months ended ...ded March 31, 2008 were $3.7 million,compared to $... Research and development expenses were $5.9 milli...
(Date:5/9/2008)...mit ultrashort pulses of light are used for numero...py, laser eye surgery, spectroscopy and controllin...ts is limited by distortions caused by lenses and ...rimental instrumentation. , To better understan...itute of Technology developed the first device to ...
Breaking Biology Technology:Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 2Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 3Volcano Announces Placement of 1,000th s5 and s5i IVUS Imaging System 4Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 2Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 3Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 4Neurobiological Technologies Reports Third Quarter Financial Results 2Neurobiological Technologies Reports Third Quarter Financial Results 3Neurobiological Technologies Reports Third Quarter Financial Results 4Neurobiological Technologies Reports Third Quarter Financial Results 5New technique measures ultrashort laser pulses at focus 2New technique measures ultrashort laser pulses at focus 3
... , a producer of automotive systems and facility m...ents and systems at the 2004 North American Inter...ry in Detroit. , ,Among the products and concepts ...omy and Ergonomics) Concept Interior -- an example...niversal appeal for several generations of consume...
...o access venture capital and partner with Canadian... 2004 The BioPartnering North America conference ...in Biotechnology Association and Wisconsins Depar...for the states biotech companies to participate in... are seeking strategic partnerships or capital are...
...s of Electricity Could Be Saved , ,The current s... after the California Energy Crisis and the Blacko...was a time when the major power for change in the ...he federal government and individual state public ...nent of each decision made by those parties was ei...
...Inc. , a rich media solutions company, today annou...30, 2003. During fiscal 2003, the company complete...off both its Media Services and Desktop Software d...b communications market. , ,Sonic Foundry finishe...with early stage business development efforts for ...
Other Biology Technology:International Biopartnering 2Wisconsins Businesses Can Become Environmental Leaders 2Wisconsins Businesses Can Become Environmental Leaders 3Sonic Foundry Reports Fiscal 2003 Results 2
(Date:5/9/2008)...HMOND, Calif., May 7 /PRNewswire-FirstCall/ -- San...today that Edward Lanphier, Sangamo,s,president an...angamo,s ZFP,Therapeutic development programs and ...7:40 p.m. (ET) on Tuesday, May 13, 2008 at the Ban... The presentation will be webcast live and may be ...
(Date:5/9/2008)...TON ROUGE Theres no doubt about it ... the platyp...ammal. With adaptations like webbed feet to fit it...rate males, the platypus represents for many a pat...Batzer, along with an international consortium of ...ity in Saint Louis, Mo., has taken this theory to ...
(Date:5/9/2008)...ORK, NY May 9, 2008 Autism Speaks, the worlds lar...the formation of an international collaboration wi...ional initiative will help to raise awareness and ...th and screening for early diagnosis and enhanced ...ve it is important to form partnerships with count...
(Date:5/9/2008)...ternational group of scientists has swapped their ...le environments on the planet to carry out a chall...nsuring the data delivered by ESA,s ice mission Cr...entists, mainly from Denmark, UK, Germany and Cana...ion Experiment (CryoVEx) 2008, an extensive three-...
Breaking Biology News(10 mins):Sangamo BioSciences to Present at the Bank of America 2008 Healthcare Conference 2First analysis of platypus genome may impact disease prevention 2Autism Speaks announces multinational initiative 2Scientists endure Arctic for last campaign prior to CryoSat-2 launch 2Scientists endure Arctic for last campaign prior to CryoSat-2 launch 3Georgia Receives Second March of Dimes NICU Family Support 28R 29 Project 5646 1Georgia Receives Second March of Dimes NICU Family Support 28R 29 Project 5646 2Georgia Receives Second March of Dimes NICU Family Support 28R 29 Project 5646 3Effective Treatment for Fibromyalgia Featured on Oprah Winfrey Show You Dont Have to Live With That Agony 21 5641 1Effective Treatment for Fibromyalgia Featured on Oprah Winfrey Show You Dont Have to Live With That Agony 21 5641 2Empty Calorie Diet Tied to Preclinical Heart Disease 5636 1Imaging Diagnostic Systems Expands Key Patent Coverage 1703 1Imaging Diagnostic Systems Expands Key Patent Coverage 1703 2Imaging Diagnostic Systems Expands Key Patent Coverage 1703 3
...sue in neuroscience, Aldo Faisal and Simon Laughli...ility of thin axons for transmitting information. ...e brain are much larger than previously assumed ?m.... , Neurons in the cerebral cortex of the brain c...sing incredibly thin axons as wires, with an avera...
...eplace the tissue it sloughs off is controlled by ...al School published in the May 4 issue of Cell, ho...eneration process not only for skin, but for many ... urogenital tract. This master regulator of epithe...ose relative to the well-known tumor-suppressing p...
...k." Fuel companies aren,t touting that slogan. At ...rt by Bruce Dale, Michigan State University profes... making fuels from poplar trees and corn stalks is...Dale is internationally known for his 30 years of ... stems, leaves, stalks and trunks of plants and tr...
...hers across the nation are protesting a new and na... letter sent Monday to U.S. Secretary of the Inter...onment and Public Works, and the House Committee o...tion—spelled out in a legal opinion from the Solic...ch—will substantially weaken the federal Endangere...
Other Biology News:Master regulatory gene of epithelial stem cells identified 2Legal ruling may put endangered species in danger 2
...2-D gel marker mix was designed specifically to ai...ntains a complement of seven reduced and denatured...o those who use markers to assess 2-D system perfo...of proteins undergoing 2-D separation and analysis...
...is a completely redesigned and updated version of ...ll line of well-proven Alpha heat-pump assemblies....ance as the DNA Engine Dyad, and original Tetrad t...ls among platforms. The Tetrad 2 contains an onboa...
The DNA Engine Tetrad thermal cycler expands the envelope of discovery beyond the pioneering PTC-200 DNA Engine cycler. It has four times the capacity with a footprint only twice the size, providin
ID clarifier: platform
Biology Products: